BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1891485)

  • 1. Alprazolam and oxazepam in the treatment of anxious out-patients with depressive symptoms: a double-blind multicenter study.
    Rimón R; Kultalahti ER; Kalli A; Koskinen T; Lepola U; Naarala M; Tick E
    Pharmacopsychiatry; 1991 May; 24(3):81-4. PubMed ID: 1891485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of alprazolam and oxazepam in the treatment of anxiety.
    Väisänen E; Jalkanen E
    Acta Psychiatr Scand; 1987 May; 75(5):536-41. PubMed ID: 3604740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Alprazolam vs. oxazepam in the treatment of anxious-neurotic patients].
    Pöldinger W
    Schweiz Rundsch Med Prax; 1985 Oct; 74(44):1199-203. PubMed ID: 2867592
    [No Abstract]   [Full Text] [Related]  

  • 4. Alprazolam versus buspirone in the treatment of outpatients with generalized anxiety disorder.
    Enkelmann R
    Psychopharmacology (Berl); 1991; 105(3):428-32. PubMed ID: 1798836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled comparison of buspirone and oxazepam in generalized anxiety.
    Ansseau M; Papart P; Gérard MA; von Frenckell R; Franck G
    Neuropsychobiology; 1990-1991; 24(2):74-8. PubMed ID: 2134114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alprazolam in the treatment of anxiety disorders and mixed anxiety and depressive disorders. Results of multicenter clinical trial].
    Kiejna A; Małyszczak K; Rzewuska M; Sobucka K; Florkowski A; Rajewski A; Rajewska J; Wojtanowska M; Dabkowski M; Brzeziński R; Rybakowski J; Sep-Kowalikowa B; Gałuszko P; Nowicki Z
    Psychiatr Pol; 1996; 30(6):973-92. PubMed ID: 9132771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etizolam in the treatment of generalized anxiety disorder associated with depressive symptoms.
    Pariante F; Caddeo S; Ecari U
    Curr Med Res Opin; 1989; 11(9):543-9. PubMed ID: 2692969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study.
    Andersch S; Rosenberg NK; Kullingsjö H; Ottosson JO; Bech P; Bruun-Hansen J; Hanson L; Lorentzen K; Mellergård M; Rasmussen S
    Acta Psychiatr Scand Suppl; 1991; 365():18-27. PubMed ID: 1862730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxazepam-protriptyline: a double-blind phase II evaluation of the efficacy and safety of the combination versus placebo in neurotic, depressed and anxious psychiatric outpatients.
    Gilbert MM; Koepke HH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):825-38. PubMed ID: 813948
    [No Abstract]   [Full Text] [Related]  

  • 13. A double blind comparison of alprazolam and amitriptyline hydrochloride in the treatment of nonpsychotic depression.
    Singh AN; Nair NP; Suranyi-Cadotte B; Schwartz G; Lizondo E
    Can J Psychiatry; 1988 Apr; 33(3):218-22. PubMed ID: 3289717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of the effects of oxazepam and oxypertine in treatment of anxious depressive neuroses].
    Faidherbe J
    Acta Psychiatr Belg; 1976; 76(4):667-77. PubMed ID: 14482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary depression in panic disorder: an indicator of severity with a weak effect on outcome in alprazolam and imipramine treatment.
    Rosenberg R; Bech P; Mellergård M; Ottosson JO
    Acta Psychiatr Scand Suppl; 1991; 365():39-45. PubMed ID: 1862733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparative study of alprazolam and dothiepin hydrochloride in the treatment of anxiety associated with depression.
    Cropper M; Garner A; McEwan GD; Munt DF; Rushbrook LA; Stevens V; Baker AC
    Pharmatherapeutica; 1987; 5(2):76-82. PubMed ID: 3310018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter controlled study of oxazepam in anxious elderly outpatients.
    Koepke HH; Gold RL; Linden ME; Lion JR; Rickels K
    Psychosomatics; 1982 Jun; 23(6):641-5. PubMed ID: 6750675
    [No Abstract]   [Full Text] [Related]  

  • 18. Differential effects of alprazolam and imipramine in generalized anxiety disorder: somatic versus psychic symptoms.
    Hoehn-Saric R; McLeod DR; Zimmerli WD
    J Clin Psychiatry; 1988 Aug; 49(8):293-301. PubMed ID: 3045099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.